Correlation Between General Insurance and Krebs Biochemicals

Can any of the company-specific risk be diversified away by investing in both General Insurance and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining General Insurance and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between General Insurance and Krebs Biochemicals and, you can compare the effects of market volatilities on General Insurance and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in General Insurance with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of General Insurance and Krebs Biochemicals.

Diversification Opportunities for General Insurance and Krebs Biochemicals

0.29

Correlation Coefficient

General Insurance  Krebs Biochemicals

Modest diversification

The 3 months correlation between General and Krebs is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding General Insurance and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and General Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Insurance are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of General Insurance i.e., General Insurance and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between General Insurance and Krebs Biochemicals

Assuming the 90 days trading horizon General Insurance is expected to generate 0.96 times more return on investment than Krebs Biochemicals. However, General Insurance is 1.04 times less risky than Krebs Biochemicals. It trades about -0.02 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about -0.13 per unit of risk. If you would invest  40,310  in General Insurance on December 1, 2024 and sell it today you would lose (3,420) from holding General Insurance or give up 8.48% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

General Insurance  vs.  Krebs Biochemicals and

General Insurance

Risk-Adjusted Performance

Very Weak

Over the last 90 days General Insurance has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, General Insurance is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Krebs Biochemicals and

Risk-Adjusted Performance

Very Weak

Over the last 90 days Krebs Biochemicals and has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with General Insurance and Krebs Biochemicals

The main advantage of trading using opposite General Insurance and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if General Insurance position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.

The idea behind General Insurance and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.